7CUU | pdb_00007cuu

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with MG132


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.68 Å
  • R-Value Free: 
    0.196 (Depositor), 0.195 (DCC) 
  • R-Value Work: 
    0.165 (Depositor), 0.167 (DCC) 
  • R-Value Observed: 
    0.166 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7CUU

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 M pro .

Wang, Z.Zhao, Y.Wang, Q.Xing, Y.Feng, L.Kong, J.Peng, C.Zhang, L.Yang, H.Lu, M.

(2021) Signal Transduct Target Ther 6: 214-214

  • DOI: https://doi.org/10.1038/s41392-021-00639-8
  • Primary Citation Related Structures: 
    7CUT, 7CUU

  • Organizational Affiliation
    • Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Macromolecule Content 

  • Total Structure Weight: 69.04 kDa 
  • Atom Count: 5,591 
  • Modeled Residue Count: 612 
  • Deposited Residue Count: 612 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
3C protein
A, B
306Severe acute respiratory syndrome coronavirus 2Mutation(s): 0 
Gene Names: rep1a-1b
EC: 3.4.22.69
UniProt
Find proteins for P0DTD1 (Severe acute respiratory syndrome coronavirus 2)
Explore P0DTD1 
Go to UniProtKB:  P0DTD1
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0DTD1
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ALD
(Subject of Investigation/LOI)

Query on ALD



Download:Ideal Coordinates CCD File
D [auth A],
I [auth B]
N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide
C26 H43 N3 O5
WUJQMWDTZKIKQZ-VABKMULXSA-N
GOL

Query on GOL



Download:Ideal Coordinates CCD File
F [auth B],
G [auth B],
H [auth B]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
DMS

Query on DMS



Download:Ideal Coordinates CCD File
C [auth A],
E [auth B]
DIMETHYL SULFOXIDE
C2 H6 O S
IAZDPXIOMUYVGZ-UHFFFAOYSA-N

Biologically Interesting Molecules (External Reference) 

1 Unique

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.68 Å
  • R-Value Free:  0.196 (Depositor), 0.195 (DCC) 
  • R-Value Work:  0.165 (Depositor), 0.167 (DCC) 
  • R-Value Observed: 0.166 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 47.281α = 114.71
b = 54.971β = 99.87
c = 59.459γ = 90.45
Software Package:
Software NamePurpose
PHENIXrefinement
XSCALEdata scaling
PDB_EXTRACTdata extraction
XDSdata reduction
Cootmodel building

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other governmentChinaNational Key R&D Program of China (2017YFA0506200)
Other governmentChinaNational Natural Science Foundation of China for Excellent Young Scholars Grant (81622002 & 81861130368)
Other governmentChinaClinical Research Program of Ruijin Hospital (2018CR006)
Other governmentChinaShanghai Youth Talent Development Program (2017275)
Other governmentChinaShanghai Medical and Health Excellent Discipline Leader Development Plan (2018BR36)
Other governmentChinaShanghai Collaborative Innovation Center for Translational Medicine (TM201902)
Other governmentChinaFoundation of National Facility for Translational Medicine (Shanghai) (TMSK-2020-003)

Revision History  (Full details and data files)

  • Version 1.0: 2021-06-23
    Type: Initial release
  • Version 1.1: 2021-07-07
    Changes: Database references
  • Version 1.2: 2023-11-29
    Changes: Data collection, Database references, Refinement description
  • Version 1.3: 2024-11-13
    Changes: Structure summary